Breaking News Instant updates and real-time market news.

RXDX

Ignyta

$8.90

0.45 (5.33%)

04:55
03/24/17
03/24
04:55
03/24/17
04:55

Ignyta management to meet with JPMorgan

Meeting to be held in Dallas on March 24 hosted by JPMorgan.

  • 24

    Mar

  • 06

    Jun

RXDX Ignyta
$8.90

0.45 (5.33%)

05/11/16
PIPR
05/11/16
NO CHANGE
Target $32
PIPR
Overweight
Piper still surprised by Ignyta's 'modest valuation'
Piper Jaffray analyst Joshua Schimmer says he remains surprised by Ignyta's "modest valuation" given the company's "multiple attractive assets." Ignyta reported Q1 results last night provided some useful updates on entrectinib and taladegib, Schimmer tells investors in a research note. He keeps an Overweight rating on the shares with a $32 price target.
06/23/16
JPMS
06/23/16
INITIATION
Target $15
JPMS
Overweight
Ignyta initiated with an Overweight at JPMorgan
JPMorgan analyst Anupam Rama started Ignyta with an Overweight rating and $15 price target, saying the company's lead program entrectinib is underappreciated from both a clinical and commercial perspective. Rama also views taladegib and RXDX-105 as interesting assets and potential long-term value drivers, though they are not currently included in the valuation model used to arrive at the $15 target.
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Piper lays out top BioPharma picks for 2017
Piper Jaffray analysts laid out their top BioPharma picks for 2017. Analyst Richard Purkiss favors Pfizer (PFE) and Eli Lilly (LLY) as his top large pharma picks. Analyst Joshua Schimmer calls Gilead (GILD) and Alexion (ALXN) his top large cap picks. Analyst David Amsellem names Horizon Pharma (HZNP) his top specialty pharma pick. Piper's other top Biopharma picks for 2017 include ACADIA (ACAD), Aimmune (AIMT), Akorn (AKRX), Alnylam (ALNY), Axovant Sciences (AXON), Cara Therapeutics (CARA), CoLucid Pharmaceuticals (CLCD), Eale Pharmaceuticals (EGRX), Exelixis (EXEL), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Neurocrine (NBIX), Nektar (NKTR), Otonomy (OTIC), Reata Pharmaceuticals (RETA), Rigel Pharmaceuticals (RIGL), Ignyta (RXDX), Theravance Biopharma (TBPH), Versartis (VSAR) and Voyager Therapeutics (VYGR). The analysts look for recent momentum in BioPharma to continue in 2017. They believe innovation and potentially repatriation should lead to increased merger activity.
01/05/17
JEFF
01/05/17
NO CHANGE
JEFF
Celgene, Alkermes among Jefferies' top 2017 Biotech picks
Jefferies' Biotechnology equity research team laid out their top picks for 2017. Following a volatile two years, the biotech space seeks to achieve "greater equilibrium" in 2017, the analysts write in a research note. They cite increasing competition, slowing volumes, and ramping payer leverage as reasons to remain selective when picking stocks this year and beyond. Among large-caps, Jefferies likes Celgene (CELG) for its "best-in-class growth" and sees limited downside in Gilead (GILD) shares. In the mid-cap space, the firm favors Alkermes (ALKS) given the prospects for Vivitrol and Aristada and a "strong" neurology pipeline as well as Vertex (VRTX). Jefferies' top small-cap picks include Aevi Genomics Medicine, Alder Biopharmaceuticals (ALDR), AMAG Pharmaceuticals (AMAG), DBV Technologies (DBVT), Immunomedics (IMMU), Ignyta (RXDX), Karyopharm (KPTI), RA Pharmaceuticals (RARX), TherapeuticsMD (TXMD) and Xenon Pharmaceuticals (XENE).

TODAY'S FREE FLY STORIES

GM

General Motors

$45.42

-0.34 (-0.74%)

12:51
10/17/17
10/17
12:51
10/17/17
12:51
Hot Stocks
NY Governor says GM applying to test autonomous vehicles in state in early 2018 »

New York Governor Andrew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

IPXL

Impax

$19.95

-0.85 (-4.09%)

12:51
10/17/17
10/17
12:51
10/17/17
12:51
Recommendations
Impax analyst commentary  »

Impax combination with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

GOOGL

Alphabet Class A

$1,009.35

1.48 (0.15%)

12:50
10/17/17
10/17
12:50
10/17/17
12:50
Periodicals
Alphabet to unfold site in Toronto, Reuters reports »

Alphabet is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

WLL

Whiting Petroleum

$5.13

-0.135 (-2.57%)

12:45
10/17/17
10/17
12:45
10/17/17
12:45
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

MAR

Marriott

$114.75

-0.36 (-0.31%)

12:39
10/17/17
10/17
12:39
10/17/17
12:39
Hot Stocks
Marriott says Ed Ryan to retire as general counsel »

Marriott International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 30

    Nov

VSTM

Verastem

$4.21

-0.14 (-3.22%)

12:35
10/17/17
10/17
12:35
10/17/17
12:35
Conference/Events
Verastem management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

VALE

Vale

$10.28

-0.225 (-2.14%)

12:34
10/17/17
10/17
12:34
10/17/17
12:34
Periodicals
Vale seeks partner to invest in New Caledonia mine, FT reports »

Vale is seeking a partner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SB

Safe Bulkers

$3.21

-0.03 (-0.93%)

12:33
10/17/17
10/17
12:33
10/17/17
12:33
Conference/Events
Safe Bulkers management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

CREE

Cree

$29.28

-0.08 (-0.27%)

12:29
10/17/17
10/17
12:29
10/17/17
12:29
Technical Analysis
Technical Earnings Preview: Cree near top of range ahead of results »

The shares were trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PYPL

PayPal

$67.31

-1.35 (-1.97%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Recommendations
PayPal analyst commentary  »

PayPal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 29

    Nov

LNG

Cheniere Energy

$48.20

0.48 (1.01%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Options
Cheniere Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
10/17/17
10/17
12:25
10/17/17
12:25
General news
U.S. corporate bond update: the calendar is relatively slim »

U.S. corporate bond…

CYTR

CytRx

$0.38

-0.0142 (-3.64%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
CytRx to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
Federal Reserve Bank of Philadelphia President speaks at summit »

Federal Reserve Bank of…

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
American Association for Cancer Research holds a webinar »

Webinar entitled,…

GOOG

Alphabet

$992.00

2.32 (0.23%)

12:20
10/17/17
10/17
12:20
10/17/17
12:20
Hot Stocks
Google refreshes Google Calendar for web »

Google said in a post to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 29

    Nov

JNJ

Johnson & Johnson

$139.15

3.03 (2.23%)

12:20
10/17/17
10/17
12:20
10/17/17
12:20
Periodicals
Appeals court throws out $72M verdict against J&J, St. Louis Post-Dispatch says »

The appeals court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

12:20
10/17/17
10/17
12:20
10/17/17
12:20
General news
Treasury's $40 B 4-week bill garnered solid results »

Treasury's $40 B…

SPX

S&P 500

12:19
10/17/17
10/17
12:19
10/17/17
12:19
Hot Stocks
Trump expected to pick Fed chair before Asia trip, CNBC reports »

President Trump is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
10/17/17
10/17
12:17
10/17/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
10/17/17
10/17
12:16
10/17/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$16.21

0.135 (0.84%)

12:15
10/17/17
10/17
12:15
10/17/17
12:15
Periodicals
Snap says advertising will stay main source of revenue, Bloomberg says »

Snap's head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

HBI

Hanesbrands

$23.28

-0.11 (-0.47%)

12:15
10/17/17
10/17
12:15
10/17/17
12:15
Options
HanesBrands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
10/17/17
10/17
12:15
10/17/17
12:15
General news
U.S. equities have been waffling »

U.S. equities have been…

BC

Brunswick

$57.82

0.2324 (0.40%)

12:14
10/17/17
10/17
12:14
10/17/17
12:14
Hot Stocks
Brunswick raises quarterly dividend 15% to 19c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.